Print Page   |   Sign In   |   Register
Companies: BioRestorative Therapies, Inc. (BRTX)

Company Profile


BioRestorative Therapies, Inc. develops products and medical therapies using cell and tissue protocols, primarily involving adult stem cells, including:

Disc/Spine Program:

Our lead cell therapy candidate, brtxDISC (Disc Implanted StemCells), is a product formulated from autologous (or person's own) cultured mesenchymal stem cells ("MSCs") collected from the patient's bone marrow. We intend that the product will be used for the non-surgical treatment of protruding and bulging lumbar discs in patients suffering from chronic lumbar disc disease. The treatmentinvolves collecting a patient?s own stem cells, culturing and cryopreserving the cells, and then having a physician inject brtxDISC into the patient's damaged disc in an outpatient procedure. The treatment is intended for patients whose pain has not been alleviated by non-invasive procedures and potentially face the prospect of surgery.

ThermoStem Program:

We are developing an allogeneic cell-based therapy to target obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue ("BAT"). BAT is intended to mimic naturally occurring brown adipose depots that regulate metabolic homeostasis in humans. Initial preclinical research indicates that increased amounts of brown fat in the body may be responsible for additional caloric burning as well as reduced glucose and lipid levels. Researchers have found that people with higher levels of brown fat may have a reduced risk for obesity and diabetes.

Contact Information

40 Marcus Drive,Melville, NY 11747
Phone: (631) 760-8100

Financial Reporting/Disclosure

Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2016 10-Q
CIK 0001505497
Fiscal Year End 12/31
OTC Marketplace OTCQB

Profile Data

SIC - Industry Classification 8090 - Services-Misc Health & Allied Services, NEC
Business Status Development Stage Company a/o Apr 30, 2015
Incorporated In: DE, USA
Year of Inc. 2010
Employees 11 a/o Apr 30, 2015

Company Officers/Contacts

Mark Weinreb CEO
Edward Field President
Mandy Clyde VP, Ops., Corporate Secretary
Francisco Silva VP, R&D, Chief Scientist

Company Directors

Mark Weinreb Chairman
Robert B. Catell
John M. Desmarais

Company Notes

  • Formerly=Stem Cell Assurance, Inc. until 9-2011
  • Formerly=Traxxec, Inc. until 8-2009
  • Formerly=Columbia River Resources, Inc. until 9-2008

Service Providers

Accounting/Auditing Firm
Not Available
Legal Counsel
Certilman Balin Adler & Hyman LLP
90 Merrick Avenue
9th Floor
East Meadow, NY, 11554
United States

Investor Relations Firm
Not Available
Community Search
Sign In